ACNYCID: HA+AC
HYALURONIC ACID + AC COMPLEX
Sterile
Registered as cosmetic
With ReadyMedical Post-Treatment the pratictioner mixes sterile sonicated Hyaluronic Acid with AC Complex.
Reduces the growth of the Propionibacterium Acnes of 99.9%
Has a strong seboregulating and anti-bacterial action
Calms and soothes irritated skin reducing scratching by inhibiting the autoimmune response
recommended combined protocols
TREATMENT/TECHNOLOGY & ACTION
radiofrequency
RM Acnycid adds to RF well known tightening effect an immediate improvement of the skin texture suffering from acne scars and reduces the typical redness thanks to its anti-inflammatory action
*Dermaroller, Dermapen, Iontophoresis
After such procedures, applied in total safety even on bleeding areas, RM Acnycid immediately provides a faster healing and allows and immediate and also long lasting seboregulating and anti-bacterial action
*Chemical Peeling, Dermabrasion
After medium and strong exfoliations the application of ReadyMedical Acnycid is very much recommended to achive a deep penetration of effective anti-bacterial active ingredients
MesoJet / JetPeel
After a full MesoJet/JetPeel session, the application of RM Acnycid ensures a further unique detoxyfying, anti-bacterial and hydrating action
Stand alone
After a careful cleaning the application of RM Acnycid provides the skin with a strong detoxifying and hydrating effect that leaves the skin clean and purified for a long time
* It is recommended to apply another RM Acne during the following 24 h
EFFICACY STUDY ON READYMEDICAL : ACNYCID: HA+AC
STUDY 1
In vitro EVALUATION OF THE PROPIONIBACTERIUM ACNES GROWTH INHIBITION AFTER THE TREATMENT
WITH READYMEDICAL ACNYCID: HA + AC
WITH READYMEDICAL ACNYCID: HA + AC
The inhibitory activity of the ReadyMedical Acnycid product was evaluated by treating the Propionibacterium acnes bacterial strain with the tested product. At two time intervals (6h and 24h), 100 μl of the mixture were plated on selective agar plates in order to verify the possible inhibition of the bacterial growth of Propionibacterium acnes, represented in Figure.
The results obtained show that the ReadyMedical Acnycid product determines a decrease equal to 99.9% of the growth of the Propionibacterium acnes strain after 6 hours and after 24 hours of contact, which was highly significant under the conditions tested.
Figure: Growth inhibition of P. acnes in absence (Inoculum ctrl) and presence (100%) of the ReadyMedical Acne product after different times of contact.
STUDY 2
In vitro EVALUATION OF ANTI-INFLAMMATORY ACTIVITY OF READY MEDICAL ACNYCID HA + AC AFTER PROPIONIBACTERIUM ACNES STIMULUS ON HUMAN KERATINOCYTES
The anti-inflammatory activity of the product ReadyMedical Acnycid after stimulation with P.acnes was evaluated in HaCat cells, measuring the expression of IL-8 by an ELISA kit (2). The concentrations to be used for the anti-inflammatory assay are 56.2 and 46.4 mg/ml, based on the cell viability assay. Positive control is represented by untreated cells and stimulated with P.acnes colture.
The obtained results demonstrate a decrease in IL-8 levels, following a pro-inflammatory stimulus, in human keratinocytes treated for 8 h. Samples treated with the product ReadyMedical Acnycid show a decrease in IL-8 levels of 39.39% and 41.69% (following treatment with 56.42 and 46.4 mg/ml, respectively) compared to the stimulated control (Ctrl + P.acnes), resulted to be highly significant for both tested concentrations.
Figure: Shows the effect of 8 h treatment with the test- ed product on IL-8 production, after P. acnes stimulation.
ReadyMedical is a registered trademark of :
